コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 abortion and 0.9 (95% CI: 0.7, 1.2) for late medical abortion.
2 nd for further study of its association with medical abortion.
3 ted after childbirth and, in one case, after medical abortion.
4 g routine treatment with antibiotics for all medical abortions.
5 women who had had a previous first-trimester medical abortion (2710 women) or surgical abortion (9104
6 enters throughout the United States provided medical abortion (abortion by means of medication) princ
8 changes were paralleled by increasing use of medical abortion and cervical pre-treatment prior to sur
9 nous online consultation and instruction for medical abortion and home self-medication, with uterine
10 nce that risk differed between women who had medical abortions and those who had surgical abortions (
11 3 days after mifepristone, 200 mg, for early medical abortion, and need not be administered strictly
13 inferiority trial we recruited women seeking medical abortion at or before 9 gestational weeks at fou
16 sessing the rates of serious infection after medical abortion during a time when misoprostol was admi
18 United States, mifepristone is available for medical abortion (for use with misoprostol) only with Ri
21 rostol administration after mifepristone for medical abortion is 2 days, but more flexible intervals,
23 he 2255 women completing follow-up, complete medical abortion rates were 98% (95% confidence interval
26 ity of simple methods for safe abortion (eg, medical abortion), the increasingly widespread use of mi
27 ion status, and urban or nonurban residence, medical abortion was not associated with a significantly
29 nancy in women who had had a first-trimester medical abortion were compared with risks in women who h
30 Clostridium sordellii endometritis following medical abortion with mifepristone (also known as RU-486